These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37327561)

  • 21. Demographic, Epidemiologic, and Clinical Characteristics of Human Monkeypox Disease Pre- and Post-2022 Outbreaks: A Systematic Review and Meta-Analysis.
    Hatami H; Jamshidi P; Arbabi M; Safavi-Naini SAA; Farokh P; Izadi-Jorshari G; Mohammadzadeh B; Nasiri MJ; Zandi M; Nayebzade A; Sechi LA
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and epidemiological characteristics of mpox: A descriptive cases series in Colombia.
    Álvarez-Moreno CA; Alzate-Ángel JC; De La Hoz-Siegler IH; Bareño A; Mantilla M; Sussman O; Valderrama-Beltrán S; Rodriguez JY; Arévalo L; Andrade-Sierra J; Padilla M; Reveiz L
    Travel Med Infect Dis; 2023; 53():102594. PubMed ID: 37211342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Human Mpox - Worldwide, 2018-2021.
    McCollum AM; Shelus V; Hill A; Traore T; Onoja B; Nakazawa Y; Doty JB; Yinka-Ogunleye A; Petersen BW; Hutson CL; Lewis R
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(3):68-72. PubMed ID: 36656790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Variations in Event-Based Surveillance for Disease Outbreak Detection: Time Series Analysis.
    Ganser I; Thiébaut R; Buckeridge DL
    JMIR Public Health Surveill; 2022 Oct; 8(10):e36211. PubMed ID: 36315218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Mpox and Secondary Syphilis in an HIV Patient: A Community Hospital Experience.
    Castanares GG; D'Assumpcao C; Fang M; McPheeters R; Heidari A
    J Investig Med High Impact Case Rep; 2023; 11():23247096231165739. PubMed ID: 37052123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monkeypox outbreak: global prevalence and biological, epidemiological and clinical characteristics - observational analysis between 1970-2022.
    Meo SA; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5624-5632. PubMed ID: 35993662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using open-source intelligence to identify early signals of COVID-19 in Indonesia.
    Thamtono Y; Moa A; MacIntyre CR
    Western Pac Surveill Response J; 2021; 12(1):40-45. PubMed ID: 34094623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Misinformation and Public Health Messaging in the Early Stages of the Mpox Outbreak: Mapping the Twitter Narrative With Deep Learning.
    Edinger A; Valdez D; Walsh-Buhi E; Trueblood JS; Lorenzo-Luaces L; Rutter LA; Bollen J
    J Med Internet Res; 2023 Jun; 25():e43841. PubMed ID: 37163694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ID-Viewer: a visual analytics architecture for infectious diseases surveillance and response management in Pakistan.
    Ali MA; Ahsan Z; Amin M; Latif S; Ayyaz A; Ayyaz MN
    Public Health; 2016 May; 134():72-85. PubMed ID: 26880489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mpox Panic, Infodemic, and Stigmatization of the Two-Spirit, Lesbian, Gay, Bisexual, Transgender, Queer or Questioning, Intersex, Asexual Community: Geospatial Analysis, Topic Modeling, and Sentiment Analysis of a Large, Multilingual Social Media Database.
    Movahedi Nia Z; Bragazzi N; Asgary A; Orbinski J; Wu J; Kong J
    J Med Internet Res; 2023 May; 25():e45108. PubMed ID: 37126377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mimics of Monkeypox: Considerations for the emergency medicine clinician.
    Long B; Liang SY; Carius BM; Chavez S; Gottlieb M; Koyfman A; Brady WJ
    Am J Emerg Med; 2023 Mar; 65():172-178. PubMed ID: 36640626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features and outcome of human Mpox (Monkeypox) in Saudi Arabia: An observational study of travel-related cases.
    Assiri AM; Al-Tawfiq JA; Jokhdar HA; Algwizani AR; Albarraq AM; Alanazi KH; Alamri AH; Almohammadi EL; Abuhasan MY; Alserehi HA; Rebh FZ; Alrossais A; Alawad E; AlBahrani S
    J Infect Public Health; 2023 Mar; 16(3):341-345. PubMed ID: 36680849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreaks of human monkeypox during the COVID-19 pandemic: a systematic review for healthcare professionals.
    Nagarajan P; Howlader A; Louis LRP; Rangarajalu K
    Iran J Microbiol; 2022 Dec; 14(6):778-791. PubMed ID: 36721435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of the clinical presentation and epidemiology of the 2022 and previous Mpox outbreaks: a rapid review and meta-analysis.
    Okoli GN; Van Caeseele P; Askin N; Abou-Setta AM
    Infect Dis (Lond); 2023 Jul; 55(7):490-508. PubMed ID: 37200216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the trends in the incidence of infectious diseases using the syndromic surveillance system, early warning and response unit, Mongolia, from 2009 to 2017: a retrospective descriptive multi-year analytical study.
    Davgasuren B; Nyam S; Altangerel T; Ishdorj O; Amarjargal A; Choi JY
    BMC Infect Dis; 2019 Aug; 19(1):705. PubMed ID: 31399064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mpox in Nigeria: Perceptions and knowledge of the disease among critical stakeholders-Global public health consequences.
    Awoyomi OJ; Njoga EO; Jaja IF; Oyeleye FA; Awoyomi PO; Ibrahim MA; Saulawa MA; Galadima HB; Rowaiye AB; Olasoju TI; Idrisa JA; Olalere FDH; Olasoju MI; Adisa OH; Adetunji VE; Idemudia OO; Ezenduka EV; Oguttu JW
    PLoS One; 2023; 18(3):e0283571. PubMed ID: 36996122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events--United States, 2005-2006.
    Yoder JS; Hlavsa MC; Craun GF; Hill V; Roberts V; Yu PA; Hicks LA; Alexander NT; Calderon RL; Roy SL; Beach MJ;
    MMWR Surveill Summ; 2008 Sep; 57(9):1-29. PubMed ID: 18784642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing and fighting stigma: a lesson from the first Mpox in Veneto region of Northeast Italy-A case report.
    Baldovin T; Girolametto G; Geppini R; Bordignon M; Alaibac M
    Front Public Health; 2023; 11():1141742. PubMed ID: 37275485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CDC Domestic Mpox Response - United States, 2022-2023.
    McQuiston JH; Braden CR; Bowen MD; McCollum AM; McDonald R; Carnes N; Carter RJ; Christie A; Doty JB; Ellington S; Fehrenbach SN; Gundlapalli AV; Hutson CL; Kachur RE; Maitland A; Pearson CM; Prejean J; Quilter LAS; Rao AK; Yu Y; Mermin J
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):547-552. PubMed ID: 37200231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global mpox research in the light of the current outbreak: demands, drivers, and obstacles.
    Klingelhöfer D; Braun M; Groneberg DA; Brüggmann D
    Emerg Microbes Infect; 2023 Dec; 12(1):2210696. PubMed ID: 37143355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.